21 results
6-K
EX-1.1
IPHA
Innate Pharma
6 Feb 24
Current report (foreign)
5:05pm
share option, incentive or benefit plan, share purchase or ownership plan, long-term incentive plan, dividend reinvestment plan, inducement award
424B5
IPHA
Innate Pharma
6 Feb 24
Prospectus supplement for primary offering
5:00pm
in this offering
To the extent that options or warrants are exercised, new options are issued under our existing or future equity incentive plans, or we issue
6-K
EX-1.1
IPHA
Innate Pharma
26 Apr 23
Current report (foreign)
4:02pm
share option, incentive or benefit plan, share purchase or ownership plan, long-term incentive plan, dividend reinvestment plan, inducement award
424B5
9s8n2kyvab5ur5e8rg71
26 Apr 23
Prospectus supplement for primary offering
4:01pm
6-K
EX-1.1
zgxi30x9o1
3 May 22
Current report (foreign)
5:08pm
424B5
oxgryqws5qsx qg0s6m6
3 May 22
Prospectus supplement for primary offering
4:36pm
S-8
EX-99.1
0yoilkxj8o
12 Jul 21
Registration of securities for employees
1:42pm
6-K
EX-99.2
viomr nulzf3
8 Sep 20
Innate Pharma Reports First Half 2020 Financial Results and Business Update
6:10am
20-F
twvdyv egbdge
24 Apr 20
Annual report (foreign)
10:43am
424B4
6g1rv9lwu sf5ztb3zi
18 Oct 19
Prospectus supplement with pricing info
4:08pm
F-1/A
qm015285shzwxcxun 2f
4 Oct 19
Registration statement (foreign) (amended)
4:56pm
F-1/A
EX-1.1
ox5057qr6 8f5vwlcfh
4 Oct 19
Registration statement (foreign) (amended)
4:56pm
F-1
iz4g 5lkojuxu
20 Sep 19
Registration statement (foreign)
4:08pm
DRS/A
nzz6yq22neevp
30 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
m6dqd9ib82
19 Jul 19
Draft registration statement (amended)
12:00am